Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Cash generated from core business operations
Percentile
P29
Within normal range
vs 5Y Ago
-2.7x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-19.27M | +75.5% |
| 2024 | $-78.76M | +23.6% |
| 2023 | $-103.15M | -21.7% |
| 2022 | $-84.78M | -21.1% |
| 2021 | $-70.00M | -1087.5% |
| 2020 | $7.09M | -90.1% |
| 2019 | $71.42M | +144.4% |
| 2018 | $29.22M | -44.5% |
| 2017 | $52.65M | +47.0% |
| 2016 | $35.81M | - |